Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010

Emerg Infect Dis. 2013 Jan;19(1):133-6. doi: 10.3201/eid1901.120310.

Abstract

We studied antimicrobial-resistant Klebsiella pneumoniae for 1998-2010 by using data from The Surveillance Network. Susceptibility results (n = 3,132,354) demonstrated significant increases in resistance to all antimicrobial drugs studied, except tetracycline. Cross-resistance among carbapenem-resistant K. pneumoniae was lower for tetracycline and amikacin.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Drug Resistance, Multiple, Bacterial / physiology
  • Epidemiological Monitoring
  • Humans
  • Inpatients
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / epidemiology*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / isolation & purification
  • Klebsiella pneumoniae / physiology*
  • Longitudinal Studies
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents